{"recordsFiltered":48602,"recordsTotal":48602,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-status&start=3300","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-status&start=2700","results":[{"registry_id":"NCT01312909","publication_url":"https://clinicaltrials.gov/study/NCT01312909","title":"A Twelve-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study With Follow-up Evaluating The Safety And Efficacy Of Varenicline For Smoking Cessation In Healthy Adolescent Smokers","has_exemption":false,"start_date":"2011-04-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01898806","publication_url":"https://clinicaltrials.gov/study/NCT01898806","title":"A Phase 4 Multicenter, Randomized, Placebo Controlled Trial of 3 Doses of Intralesional Triamcinolone (KENALOG®) In the Treatment of Mild to Moderate Patch Type Alopecia Areata","has_exemption":false,"start_date":"2011-09-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported-late","is_pact":true,"days_late":50},{"registry_id":"NCT01431105","publication_url":"https://clinicaltrials.gov/study/NCT01431105","title":"Phase I/IIa Study of Pharmacokinetics and Safety of Atorvastatin in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease","has_exemption":false,"start_date":"2012-07-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported-late","is_pact":true,"days_late":60},{"registry_id":"NCT01680887","publication_url":"https://clinicaltrials.gov/study/NCT01680887","title":"A Phase II, Randomized, Double-Blind Trial of Varenicline for the Treatment of Cocaine Dependence","has_exemption":false,"start_date":"2012-08-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported-late","is_pact":true,"days_late":144},{"registry_id":"NCT01525082","publication_url":"https://clinicaltrials.gov/study/NCT01525082","title":"A Phase 2 Study of Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors","has_exemption":false,"start_date":"2012-12-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Shaheen Shagufta","sponsor_slug":"shaheen-shagufta","status":"reported-late","is_pact":true,"days_late":490},{"registry_id":"NCT01756729","publication_url":"https://clinicaltrials.gov/study/NCT01756729","title":"A Prospective, Non-randomized, Concurrent Control, Open Label, Post-approval Study of NovoTTF-100A in Recurrent GBM Patient","has_exemption":false,"start_date":"2012-12-31","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"NovoCure Ltd.","sponsor_slug":"novocure-ltd","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT01785771","publication_url":"https://clinicaltrials.gov/study/NCT01785771","title":"An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c","has_exemption":true,"start_date":"2013-05-31","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Intarcia Therapeutics","sponsor_slug":"intarcia-therapeutics","status":"overdue","is_pact":true,"days_late":1915},{"registry_id":"NCT01843023","publication_url":"https://clinicaltrials.gov/study/NCT01843023","title":"Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth","has_exemption":false,"start_date":"2013-06-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Friends Research Institute, Inc.","sponsor_slug":"friends-research-institute-inc","status":"reported-late","is_pact":true,"days_late":425},{"registry_id":"NCT01839110","publication_url":"https://clinicaltrials.gov/study/NCT01839110","title":"A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine on Outcomes in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Accompanied by a Comparative Study of Cellular Metabolism in Subjects With Pulmonary Hypertension With and Without Right Ventricular Dysfunction","has_exemption":false,"start_date":"2013-07-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01801007","publication_url":"https://clinicaltrials.gov/study/NCT01801007","title":"Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms","has_exemption":true,"start_date":"2013-07-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Microvention-Terumo, Inc.","sponsor_slug":"microvention-terumo-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01892813","publication_url":"https://clinicaltrials.gov/study/NCT01892813","title":"Tailored Tobacco Intervention","has_exemption":false,"start_date":"2013-07-31","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Mark Vander Weg","sponsor_slug":"mark-vander-weg","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT01950455","publication_url":"https://clinicaltrials.gov/study/NCT01950455","title":"Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes","has_exemption":false,"start_date":"2013-11-30","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Navidea Biopharmaceuticals","sponsor_slug":"navidea-biopharmaceuticals","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT01983293","publication_url":"https://clinicaltrials.gov/study/NCT01983293","title":"Cardiac Resynchronization Therapy (CRT) Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients (ENHANCE CRT). A Prospective, Randomized, Postmarket, Pilot Study.","has_exemption":false,"start_date":"2013-11-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02383407","publication_url":"https://clinicaltrials.gov/study/NCT02383407","title":"Low Frequency Electrical Stimulation of the Fornix in Intractable Mesial Temporal Lobe Epilepsy (MTLE)","has_exemption":false,"start_date":"2013-12-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"George Washington University","sponsor_slug":"george-washington-university","status":"reported-late","is_pact":true,"days_late":1484},{"registry_id":"NCT01967888","publication_url":"https://clinicaltrials.gov/study/NCT01967888","title":"A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Assignment Study to Assess the Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation","has_exemption":false,"start_date":"2014-02-28","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Dompé Farmaceutici S.p.A","sponsor_slug":"dompe-farmaceutici-spa","status":"reported-late","is_pact":true,"days_late":227},{"registry_id":"NCT02021929","publication_url":"https://clinicaltrials.gov/study/NCT02021929","title":"Sorafenib in Patients With Hepatopulmonary Syndrome: A Double-Blind Randomized Clinical Trial","has_exemption":false,"start_date":"2014-03-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported-late","is_pact":true,"days_late":25},{"registry_id":"NCT02071979","publication_url":"https://clinicaltrials.gov/study/NCT02071979","title":"Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds","has_exemption":false,"start_date":"2014-04-30","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Arteriocyte, Inc.","sponsor_slug":"arteriocyte-inc","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT02096952","publication_url":"https://clinicaltrials.gov/study/NCT02096952","title":"Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder Adults With Attention-Deficit/Hyperactivity Disorder","has_exemption":false,"start_date":"2014-05-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02132195","publication_url":"https://clinicaltrials.gov/study/NCT02132195","title":"Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome","has_exemption":false,"start_date":"2014-05-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported-late","is_pact":true,"days_late":32},{"registry_id":"NCT02101918","publication_url":"https://clinicaltrials.gov/study/NCT02101918","title":"Perfusion CT as Predictive Biomarker in a Phase II Study of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors","has_exemption":false,"start_date":"2014-06-18","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":99},{"registry_id":"NCT02064725","publication_url":"https://clinicaltrials.gov/study/NCT02064725","title":"A Phase II Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Progesterone Receptor Negative Recurrent or Persistent Endometrial Carcinoma","has_exemption":false,"start_date":"2014-09-30","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Kevelt AS","sponsor_slug":"kevelt-as","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT02268175","publication_url":"https://clinicaltrials.gov/study/NCT02268175","title":"A Phase II Randomized Study of Enzalutamide+Leuprolide Versus Enzalutamide+Leuprolide+Abiraterone Acetate+Prednisone as Neoadjuvant Therapy for HIgh-Risk Prostate Cancer Undergoing Prostatectomy","has_exemption":false,"start_date":"2014-10-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported-late","is_pact":true,"days_late":232},{"registry_id":"NCT02145039","publication_url":"https://clinicaltrials.gov/study/NCT02145039","title":"Reduced Intensity Conditioning (RIC) and Transplantation of HLA(Human Leukocyte Antigen)-Haploidentical Related Bone Marrow (Haplo-BM) For Patients With Hematologic Diseases","has_exemption":false,"start_date":"2014-10-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"reported-late","is_pact":true,"days_late":252},{"registry_id":"NCT02331251","publication_url":"https://clinicaltrials.gov/study/NCT02331251","title":"A Phase Ib/II Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)","has_exemption":false,"start_date":"2014-12-31","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Western Regional Medical Center","sponsor_slug":"western-regional-medical-center","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT02343575","publication_url":"https://clinicaltrials.gov/study/NCT02343575","title":"Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU","has_exemption":false,"start_date":"2015-01-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported-late","is_pact":true,"days_late":120},{"registry_id":"NCT02397057","publication_url":"https://clinicaltrials.gov/study/NCT02397057","title":"A Double-Blinded, Multi-Center, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Restless Legs Syndrome (RLS)","has_exemption":false,"start_date":"2015-01-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"American Regent, Inc.","sponsor_slug":"american-regent-inc","status":"reported-late","is_pact":true,"days_late":641},{"registry_id":"NCT02284906","publication_url":"https://clinicaltrials.gov/study/NCT02284906","title":"A Blinded Long-term Extension Study to Evaluate the Safety and Efficacy of Pioglitazone (AD-4833 Sustained Release 0.8 mg Daily) to Slow the Progression of Cognitive Decline in Subjects Who Have Completed the AD-4833/TOMM40_301 Study With Diagnosis of Mild Cognitive Impairment Due to Alzheimer Disease","has_exemption":false,"start_date":"2015-02-12","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported-late","is_pact":true,"days_late":96},{"registry_id":"NCT02393417","publication_url":"https://clinicaltrials.gov/study/NCT02393417","title":"A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)","has_exemption":false,"start_date":"2015-03-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Nielsen BioSciences, Inc.","sponsor_slug":"nielsen-biosciences-inc","status":"reported-late","is_pact":true,"days_late":68},{"registry_id":"NCT02504645","publication_url":"https://clinicaltrials.gov/study/NCT02504645","title":"A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2015-03-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"ImmuPharma","sponsor_slug":"immupharma","status":"reported-late","is_pact":true,"days_late":12},{"registry_id":"NCT02431260","publication_url":"https://clinicaltrials.gov/study/NCT02431260","title":"A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054329 in Subjects With Advanced Malignancies","has_exemption":false,"start_date":"2015-04-14","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02408445","publication_url":"https://clinicaltrials.gov/study/NCT02408445","title":"Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment","has_exemption":false,"start_date":"2015-05-08","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"reported-late","is_pact":true,"days_late":21},{"registry_id":"NCT02228681","publication_url":"https://clinicaltrials.gov/study/NCT02228681","title":"A Randomized Phase II Trial of Everolimus and Letrozole or Hormonal Therapy (Tamoxifen/Medroxyprogesterone Acetate) in Women With Advanced, Recurrent, or Persistent Endometria Carcinoma","has_exemption":false,"start_date":"2015-05-21","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"GOG Foundation","sponsor_slug":"gog-foundation","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02453334","publication_url":"https://clinicaltrials.gov/study/NCT02453334","title":"IRON CLAD: Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Multi-center, Randomized, Double-blinded, Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose Injection) in Adults","has_exemption":false,"start_date":"2015-05-23","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"American Regent, Inc.","sponsor_slug":"american-regent-inc","status":"reported-late","is_pact":true,"days_late":641},{"registry_id":"NCT02450552","publication_url":"https://clinicaltrials.gov/study/NCT02450552","title":"A Phase 2 Pharmacodynamic Trial of Ezogabine (Retigabine) on Neuronal Excitability in Amyotrophic Lateral Sclerosis","has_exemption":false,"start_date":"2015-06-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Brian Wainger","sponsor_slug":"brian-wainger","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02371187","publication_url":"https://clinicaltrials.gov/study/NCT02371187","title":"Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?","has_exemption":false,"start_date":"2015-06-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Christopher Bell","sponsor_slug":"christopher-bell","status":"reported-late","is_pact":true,"days_late":1},{"registry_id":"NCT02665273","publication_url":"https://clinicaltrials.gov/study/NCT02665273","title":"A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine","has_exemption":false,"start_date":"2015-07-01","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"reported-late","is_pact":true,"days_late":280},{"registry_id":"NCT02437890","publication_url":"https://clinicaltrials.gov/study/NCT02437890","title":"A Phase II Multicenter, Randomized, Double-blind, Placebo Controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX-0061 Administered Subcutaneously in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus","has_exemption":true,"start_date":"2015-07-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Ablynx, a Sanofi company","sponsor_slug":"ablynx-a-sanofi-company","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02473952","publication_url":"https://clinicaltrials.gov/study/NCT02473952","title":"A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2015-08-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02369211","publication_url":"https://clinicaltrials.gov/study/NCT02369211","title":"Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV) in Patients Undergoing Robotic-assisted Laparoscopic Prostatectomy","has_exemption":false,"start_date":"2015-09-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported-late","is_pact":true,"days_late":184},{"registry_id":"NCT02455011","publication_url":"https://clinicaltrials.gov/study/NCT02455011","title":"A Randomized, Placebo-controlled, Double-blind, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeated Subcutaneous (SC) Doses of REMD-477 in Subjects With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2015-09-30","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"REMD Biotherapeutics, Inc.","sponsor_slug":"remd-biotherapeutics-inc","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT02586688","publication_url":"https://clinicaltrials.gov/study/NCT02586688","title":"A Randomized, Sham-Controlled Trial Evaluating the Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents","has_exemption":false,"start_date":"2015-10-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Neuronetics","sponsor_slug":"neuronetics","status":"reported-late","is_pact":true,"days_late":1048},{"registry_id":"NCT02314156","publication_url":"https://clinicaltrials.gov/study/NCT02314156","title":"Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy","has_exemption":false,"start_date":"2015-10-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"reported-late","is_pact":true,"days_late":1379},{"registry_id":"NCT02640820","publication_url":"https://clinicaltrials.gov/study/NCT02640820","title":"A Prospective, Phase 2a Study to Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) in Subjects Ages 18 - 65 Years","has_exemption":false,"start_date":"2015-12-31","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"RXi Pharmaceuticals, Corp.","sponsor_slug":"rxi-pharmaceuticals-corp","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT02652780","publication_url":"https://clinicaltrials.gov/study/NCT02652780","title":"Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene","has_exemption":false,"start_date":"2016-01-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"GenSight Biologics","sponsor_slug":"gensight-biologics","status":"reported-late","is_pact":true,"days_late":316},{"registry_id":"NCT02596906","publication_url":"https://clinicaltrials.gov/study/NCT02596906","title":"Brain and Cognitive Changes After Reasoning Training in Individuals With Cognitive Complaints","has_exemption":false,"start_date":"2016-01-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"reported-late","is_pact":true,"days_late":447},{"registry_id":"NCT03887754","publication_url":"https://clinicaltrials.gov/study/NCT03887754","title":"Therapeutic Issues for Autism Spectrum Disorders: a Clinical Trial","has_exemption":false,"start_date":"2016-01-31","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Minia University","sponsor_slug":"minia-university","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT06229639","publication_url":"https://clinicaltrials.gov/study/NCT06229639","title":"Assessing the Safety of the Nocturnal Passy Muir Valve and Its Impact on Sleep Quality in an LTACH Setting","has_exemption":false,"start_date":"2016-01-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Gaylord Hospital, Inc","sponsor_slug":"gaylord-hospital-inc","status":"reported-late","is_pact":true,"days_late":2475},{"registry_id":"NCT02833415","publication_url":"https://clinicaltrials.gov/study/NCT02833415","title":"Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging","has_exemption":false,"start_date":"2016-03-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"reported-late","is_pact":true,"days_late":26},{"registry_id":"NCT02704130","publication_url":"https://clinicaltrials.gov/study/NCT02704130","title":"Transarterial Embolization and Microwave Ablation Combination Therapy in Early-stage Hepatocellular Carcinoma: A Randomized Trial","has_exemption":false,"start_date":"2016-03-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":true,"days_late":1005},{"registry_id":"NCT02734849","publication_url":"https://clinicaltrials.gov/study/NCT02734849","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Study to Evaluate Multiple Doses of AK001 in Patients With Moderate to Severe Nasal Polyposis","has_exemption":true,"start_date":"2016-04-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Allakos, Inc.","sponsor_slug":"allakos-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02730962","publication_url":"https://clinicaltrials.gov/study/NCT02730962","title":"Interventional Bioremediation of Microbiota in Metabolic Syndrome","has_exemption":false,"start_date":"2016-06-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported-late","is_pact":true,"days_late":148},{"registry_id":"NCT02781324","publication_url":"https://clinicaltrials.gov/study/NCT02781324","title":"Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis - Randomized Clinical Trial","has_exemption":false,"start_date":"2016-06-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"reported-late","is_pact":true,"days_late":102},{"registry_id":"NCT02633501","publication_url":"https://clinicaltrials.gov/study/NCT02633501","title":"P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)","has_exemption":false,"start_date":"2016-06-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Guerbet","sponsor_slug":"guerbet","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02858908","publication_url":"https://clinicaltrials.gov/study/NCT02858908","title":"A Single-Blind, Phase 2 Study To Evaluate The Safety And Efficacy Of Tideglusib 400mg Or 1000mg For The Treatment Of Adolescent And Adult Congenital And Juvenile-Onset Myotonic Dystrophy","has_exemption":true,"start_date":"2016-07-20","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"AMO Pharma Limited","sponsor_slug":"amo-pharma-limited","status":"reported-late","is_pact":true,"days_late":1586},{"registry_id":"NCT02745119","publication_url":"https://clinicaltrials.gov/study/NCT02745119","title":"A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Lampalizumab in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration Who Have Completed a Roche-Sponsored Study","has_exemption":true,"start_date":"2016-07-21","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02813694","publication_url":"https://clinicaltrials.gov/study/NCT02813694","title":"A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia","has_exemption":true,"start_date":"2016-08-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Nabriva Therapeutics AG","sponsor_slug":"nabriva-therapeutics-ag","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02855359","publication_url":"https://clinicaltrials.gov/study/NCT02855359","title":"An Open Label Phase 2 Study of Denintuzumab Mafodotin (SGN-CD19A) in Combination With RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) or RCHP (Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone) Compared With RCHOP Alone as Frontline Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) Grade 3b","has_exemption":false,"start_date":"2016-08-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Seagen Inc.","sponsor_slug":"seagen-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02951195","publication_url":"https://clinicaltrials.gov/study/NCT02951195","title":"A Phase 2, Randomized, Double Blind, Controlled Study to Evaluate the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis","has_exemption":true,"start_date":"2016-11-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02969187","publication_url":"https://clinicaltrials.gov/study/NCT02969187","title":"Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized, Double-Blind, Controlled Trial","has_exemption":false,"start_date":"2016-11-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"reported-late","is_pact":true,"days_late":159},{"registry_id":"NCT02953678","publication_url":"https://clinicaltrials.gov/study/NCT02953678","title":"A Single-Cohort, Phase 2 Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)","has_exemption":true,"start_date":"2016-12-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02967133","publication_url":"https://clinicaltrials.gov/study/NCT02967133","title":"Nivolumab With or Without Nab-Paclitaxel in Previously Treated, Advanced Stage, Non-small Cell Lung Cancer: A Randomized Phase II Study","has_exemption":false,"start_date":"2016-12-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Alliance Foundation Trials, LLC.","sponsor_slug":"alliance-foundation-trials-llc","status":"reported-late","is_pact":true,"days_late":1258},{"registry_id":"NCT03013790","publication_url":"https://clinicaltrials.gov/study/NCT03013790","title":"Melatonin Use in the Intensive Care Elderly Population","has_exemption":false,"start_date":"2016-12-31","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"MICE Trial Group","sponsor_slug":"mice-trial-group","status":"overdue","is_pact":true,"days_late":2646},{"registry_id":"NCT03137186","publication_url":"https://clinicaltrials.gov/study/NCT03137186","title":"Mansmed Trial : Repurposing Metformin as Anticancer Drug, RCT in Advanced Prostate Cancer","has_exemption":false,"start_date":"2017-01-31","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Mansoura University","sponsor_slug":"mansoura-university","status":"overdue","is_pact":false,"days_late":2646},{"registry_id":"NCT03106948","publication_url":"https://clinicaltrials.gov/study/NCT03106948","title":"Balloon Angioplasty of Dialysis AV Fistulae: Effect of Local Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis","has_exemption":false,"start_date":"2017-02-01","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Southeast Renal Research Institute","sponsor_slug":"southeast-renal-research-institute","status":"overdue","is_pact":false,"days_late":2646},{"registry_id":"NCT03076515","publication_url":"https://clinicaltrials.gov/study/NCT03076515","title":"A Prospective, Randomized, Double-blind, Sham Controlled Multi-center Clinical Trial, Migraine Headache Treatment With Nerivio Migra Neurostimulation Device","has_exemption":false,"start_date":"2017-04-02","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Theranica","sponsor_slug":"theranica","status":"reported-late","is_pact":false,"days_late":222},{"registry_id":"NCT03118297","publication_url":"https://clinicaltrials.gov/study/NCT03118297","title":"Intervention to End Recurrent Unscheduled Bleeding Trial: A Randomized-controlled Trial of Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users","has_exemption":false,"start_date":"2017-05-01","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03053518","publication_url":"https://clinicaltrials.gov/study/NCT03053518","title":"Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes","has_exemption":false,"start_date":"2017-06-30","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported-late","is_pact":false,"days_late":578},{"registry_id":"NCT02929498","publication_url":"https://clinicaltrials.gov/study/NCT02929498","title":"A Phase I/II, Open-label, 2 Arm Study to Investigate the Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of GSK2879552 Administered Alone or in Combination With Azacitidine, in Adult Subjects With IPSS-R High and Very High Risk Myelodysplastic Syndromes (MDS) Previously Treated With Hypomethylating Agents (HMA)","has_exemption":false,"start_date":"2017-07-31","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported-late","is_pact":false,"days_late":12},{"registry_id":"NCT03262610","publication_url":"https://clinicaltrials.gov/study/NCT03262610","title":"Expanded-access for the Use of Setmelanotide in a Single Patient With Partial Lipodystrophy (LD) Associated With Leptin Deficiency and Multiple Autoimmune Diseases","has_exemption":false,"start_date":"2017-08-15","completion_date":"2018-01-31","has_results":false,"results_due":true,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"reported-late","is_pact":false,"days_late":1545},{"registry_id":"NCT03137992","publication_url":"https://clinicaltrials.gov/study/NCT03137992","title":"A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Crossover, Multicenter Clinical Study to Assess the Efficacy and Safety of Once Daily Administration of Lupin Tiotropium Bromide Inhalation Powder Compared to SPIRIVA® HANDIHALER® and Placebo in Patients With COPD Including a 12-Week Open Label Extension to Assess Inhaler Robustness","has_exemption":true,"start_date":"2017-11-21","completion_date":"2018-01-31","has_results":true,"results_due":true,"sponsor_name":"Lupin, Inc.","sponsor_slug":"lupin-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00794040","publication_url":"https://clinicaltrials.gov/study/NCT00794040","title":"A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation","has_exemption":false,"start_date":"2008-11-17","completion_date":"2018-02-01","has_results":true,"results_due":true,"sponsor_name":"National Institute of Mental Health (NIMH)","sponsor_slug":"national-institute-of-mental-health-nimh","status":"reported-late","is_pact":true,"days_late":49},{"registry_id":"NCT02049502","publication_url":"https://clinicaltrials.gov/study/NCT02049502","title":"The Use of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis-associated Pouchitis","has_exemption":false,"start_date":"2014-07-31","completion_date":"2018-02-01","has_results":true,"results_due":true,"sponsor_name":"Virginia O. Shaffer","sponsor_slug":"virginia-o-shaffer","status":"reported-late","is_pact":true,"days_late":22},{"registry_id":"NCT02292017","publication_url":"https://clinicaltrials.gov/study/NCT02292017","title":"A Prospective Single Center Trial Investigating the Effects of Prospectively Measuring Packing Density Prior to Choosing Target Coils for the Treatment of Intracranial Saccular Aneurysms.","has_exemption":false,"start_date":"2014-10-31","completion_date":"2018-02-01","has_results":false,"results_due":true,"sponsor_name":"Tennessee Neurovascular Institute, LLC","sponsor_slug":"tennessee-neurovascular-institute-llc","status":"overdue","is_pact":true,"days_late":2645},{"registry_id":"NCT03053089","publication_url":"https://clinicaltrials.gov/study/NCT03053089","title":"A Two-Stage, Phase 1/2, Open-Label Study of the Human Insulin Receptor Monoclonal Antibody-Human Alpha-L-iduronidase (HIRMAb-IDUA) Fusion Protein, AGT-181 in Patients With Mucopolysaccharidosis I (MPS I, Hurler Syndrome)","has_exemption":false,"start_date":"2015-10-31","completion_date":"2018-02-01","has_results":false,"results_due":true,"sponsor_name":"ArmaGen, Inc","sponsor_slug":"armagen-inc","status":"reported-late","is_pact":true,"days_late":2209},{"registry_id":"NCT02354859","publication_url":"https://clinicaltrials.gov/study/NCT02354859","title":"A Phase 2, Multi-Center, Randomized, Placebo-Controlled Study of IV Gallium Nitrate in Patients With Cystic Fibrosis (IGNITE Study)","has_exemption":false,"start_date":"2016-03-31","completion_date":"2018-02-01","has_results":true,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02951351","publication_url":"https://clinicaltrials.gov/study/NCT02951351","title":"Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections","has_exemption":false,"start_date":"2016-10-12","completion_date":"2018-02-01","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported-late","is_pact":true,"days_late":59},{"registry_id":"NCT03071341","publication_url":"https://clinicaltrials.gov/study/NCT03071341","title":"An Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Patients With Mucopolysaccharidosis I Who Were Previously Enrolled in Studies With AGT-181","has_exemption":false,"start_date":"2016-10-31","completion_date":"2018-02-01","has_results":false,"results_due":true,"sponsor_name":"ArmaGen, Inc","sponsor_slug":"armagen-inc","status":"overdue","is_pact":true,"days_late":2645},{"registry_id":"NCT03451396","publication_url":"https://clinicaltrials.gov/study/NCT03451396","title":"Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms","has_exemption":false,"start_date":"2016-12-12","completion_date":"2018-02-01","has_results":false,"results_due":true,"sponsor_name":"Lifelong Vision Foundation","sponsor_slug":"lifelong-vision-foundation","status":"overdue","is_pact":true,"days_late":2645},{"registry_id":"NCT03011333","publication_url":"https://clinicaltrials.gov/study/NCT03011333","title":"A Phase 2B, Randomized, Controlled Study of HTX-011 Administered Via Pectoral Nerve Block in Subjects Undergoing Upper Extremity Surgery for Augmentation Mammoplasty","has_exemption":true,"start_date":"2017-01-14","completion_date":"2018-02-01","has_results":true,"results_due":true,"sponsor_name":"Heron Therapeutics","sponsor_slug":"heron-therapeutics","status":"reported-late","is_pact":true,"days_late":133},{"registry_id":"NCT02967458","publication_url":"https://clinicaltrials.gov/study/NCT02967458","title":"Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study","has_exemption":false,"start_date":"2017-02-01","completion_date":"2018-02-01","has_results":true,"results_due":true,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03101501","publication_url":"https://clinicaltrials.gov/study/NCT03101501","title":"A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.","has_exemption":false,"start_date":"2017-02-14","completion_date":"2018-02-01","has_results":false,"results_due":true,"sponsor_name":"Key-Whitman Eye Center","sponsor_slug":"key-whitman-eye-center","status":"overdue","is_pact":false,"days_late":2645},{"registry_id":"NCT03033134","publication_url":"https://clinicaltrials.gov/study/NCT03033134","title":"A Study to Evaluate the Safety and Effectiveness of the Left Atrial Appendage Closure Therapy Using BSJ003W for Patients With Non-valvular Atrial Fibrillation at Increased Risk of ThromboEmbolism in Japanese Medical Environment (SALUTE)","has_exemption":false,"start_date":"2017-02-27","completion_date":"2018-02-01","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Japan K.K.","sponsor_slug":"boston-scientific-japan-kk","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03853200","publication_url":"https://clinicaltrials.gov/study/NCT03853200","title":"In-vivo Comparison of Antibacterial Efficacy of Three Different Solutions as Final Irrigant During Endodontic Therapy: A Randomized Controlled Trial","has_exemption":false,"start_date":"2017-04-03","completion_date":"2018-02-01","has_results":false,"results_due":true,"sponsor_name":"Dow University of Health Sciences","sponsor_slug":"dow-university-of-health-sciences","status":"overdue","is_pact":false,"days_late":2645},{"registry_id":"NCT03251079","publication_url":"https://clinicaltrials.gov/study/NCT03251079","title":"PRECISION Study: A Prospective, Multi-center Evaluation of Precision, Compression and Performance of a Novel Implanted Continuous Glucose Sensor Using a Next Generation Transmitter and Algorithm","has_exemption":false,"start_date":"2017-07-25","completion_date":"2018-02-01","has_results":true,"results_due":true,"sponsor_name":"Senseonics, Inc.","sponsor_slug":"senseonics-inc","status":"reported-late","is_pact":false,"days_late":1752},{"registry_id":"NCT03256487","publication_url":"https://clinicaltrials.gov/study/NCT03256487","title":"Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department","has_exemption":false,"start_date":"2017-09-26","completion_date":"2018-02-01","has_results":false,"results_due":true,"sponsor_name":"Alameda Health System","sponsor_slug":"alameda-health-system","status":"overdue","is_pact":false,"days_late":2645},{"registry_id":"NCT01576016","publication_url":"https://clinicaltrials.gov/study/NCT01576016","title":"Accent Magnetic Resonance Imaging Pacemaker and Tendril Magnetic Resonance Imaging™ Lead Investigational Device Exemption Study","has_exemption":false,"start_date":"2012-03-30","completion_date":"2018-02-02","has_results":true,"results_due":true,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"reported-late","is_pact":true,"days_late":195},{"registry_id":"NCT01871545","publication_url":"https://clinicaltrials.gov/study/NCT01871545","title":"Evaluation of HCC Response to Systemic Therapy With Quantitative MRI","has_exemption":false,"start_date":"2013-06-30","completion_date":"2018-02-02","has_results":true,"results_due":true,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"reported-late","is_pact":true,"days_late":469},{"registry_id":"NCT03559829","publication_url":"https://clinicaltrials.gov/study/NCT03559829","title":"Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke","has_exemption":false,"start_date":"2016-09-23","completion_date":"2018-02-02","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported-late","is_pact":true,"days_late":41},{"registry_id":"NCT02969408","publication_url":"https://clinicaltrials.gov/study/NCT02969408","title":"A 12-Week, Open-Label Study to Evaluate the Relationship Between Use of Albuterol eMDPI, an Inhaled Short-Acting Beta Agonist \"Rescue\" Agent With an eModule, and Exacerbations in Patients (18 Years of Age or Older) With Asthma","has_exemption":false,"start_date":"2017-02-13","completion_date":"2018-02-02","has_results":true,"results_due":true,"sponsor_name":"Teva Branded Pharmaceutical Products, R&D Inc.","sponsor_slug":"teva-branded-pharmaceutical-products-rd-inc","status":"reported-late","is_pact":false,"days_late":69},{"registry_id":"NCT02060383","publication_url":"https://clinicaltrials.gov/study/NCT02060383","title":"A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly","has_exemption":true,"start_date":"2014-05-23","completion_date":"2018-02-05","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02326337","publication_url":"https://clinicaltrials.gov/study/NCT02326337","title":"A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers","has_exemption":false,"start_date":"2014-10-31","completion_date":"2018-02-05","has_results":true,"results_due":true,"sponsor_name":"AOTI Ltd.","sponsor_slug":"aoti-ltd","status":"reported-late","is_pact":true,"days_late":906},{"registry_id":"NCT02590432","publication_url":"https://clinicaltrials.gov/study/NCT02590432","title":"An Open-label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.","has_exemption":false,"start_date":"2015-11-01","completion_date":"2018-02-05","has_results":true,"results_due":true,"sponsor_name":"Forest Laboratories","sponsor_slug":"forest-laboratories","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02670915","publication_url":"https://clinicaltrials.gov/study/NCT02670915","title":"Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes","has_exemption":false,"start_date":"2016-05-04","completion_date":"2018-02-05","has_results":true,"results_due":true,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03264248","publication_url":"https://clinicaltrials.gov/study/NCT03264248","title":"Daily Self-weighing Feedback for Wheelchair Users to Promote Weight Loss Through Use of the E-scale","has_exemption":false,"start_date":"2017-07-01","completion_date":"2018-02-05","has_results":true,"results_due":true,"sponsor_name":"Jonathan Pearlman","sponsor_slug":"jonathan-pearlman","status":"reported-late","is_pact":false,"days_late":26},{"registry_id":"NCT03245385","publication_url":"https://clinicaltrials.gov/study/NCT03245385","title":"An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2017-07-24","completion_date":"2018-02-05","has_results":false,"results_due":true,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"reported-late","is_pact":false,"days_late":1001},{"registry_id":"NCT03428997","publication_url":"https://clinicaltrials.gov/study/NCT03428997","title":"Human Comedogenicity Test","has_exemption":false,"start_date":"2017-11-20","completion_date":"2018-02-05","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Consumer Inc. (J&JCI)","sponsor_slug":"johnson-johnson-consumer-inc-jjci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01550367","publication_url":"https://clinicaltrials.gov/study/NCT01550367","title":"Inhibiting the Systemic Autophagic Syndrome - A Phase I/II Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC). A Cytokine Working Group (CWG) Study","has_exemption":false,"start_date":"2012-03-31","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"Leonard Appleman","sponsor_slug":"leonard-appleman","status":"reported-late","is_pact":true,"days_late":161},{"registry_id":"NCT01978184","publication_url":"https://clinicaltrials.gov/study/NCT01978184","title":"Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine","has_exemption":false,"start_date":"2013-11-30","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"Nathan Bahary, MD","sponsor_slug":"nathan-bahary-md","status":"reported-late","is_pact":true,"days_late":25},{"registry_id":"NCT02267603","publication_url":"https://clinicaltrials.gov/study/NCT02267603","title":"A Phase II Study of MK-3475 in Patients With Advanced Merkel Cell Carcinoma (MCC)","has_exemption":false,"start_date":"2014-11-25","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02522767","publication_url":"https://clinicaltrials.gov/study/NCT02522767","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 4 g Extended Release Granules (Sachet) for the Induction of Clinical and Endoscopic Remission in Active, Mild to Moderate Ulcerative Colitis","has_exemption":true,"start_date":"2015-10-31","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"Ferring Pharmaceuticals","sponsor_slug":"ferring-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02833077","publication_url":"https://clinicaltrials.gov/study/NCT02833077","title":"A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation","has_exemption":true,"start_date":"2016-06-28","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02972632","publication_url":"https://clinicaltrials.gov/study/NCT02972632","title":"An Open-Label, Single-Arm, Multicenter, Prospective, Phase 4, Interventional, Flexible Dose Study to Evaluate the Effectiveness of Vortioxetine on Goal Achievement After a Change in Antidepressant Medication for the Treatment of Subjects With Major Depressive Disorder","has_exemption":false,"start_date":"2016-12-22","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02905331","publication_url":"https://clinicaltrials.gov/study/NCT02905331","title":"A Phase 3, Multicenter, Randomized, Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) Delivered Via a SelfDose (TM) Device in the Treatment of Subjects With Moderate to Severe Plaque-Type Psoriasis","has_exemption":false,"start_date":"2017-02-28","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02856828","publication_url":"https://clinicaltrials.gov/study/NCT02856828","title":"Novel Use of an Enhanced Fluoroscopic Imaging Device to Reduce Radiation Exposure and Operative Time During Intramedullary Nailing of Hip Fractures","has_exemption":true,"start_date":"2017-03-01","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03195140","publication_url":"https://clinicaltrials.gov/study/NCT03195140","title":"Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes","has_exemption":false,"start_date":"2017-08-11","completion_date":"2018-02-06","has_results":true,"results_due":true,"sponsor_name":"Tandem Diabetes Care, Inc.","sponsor_slug":"tandem-diabetes-care-inc","status":"reported-late","is_pact":false,"days_late":1710},{"registry_id":"NCT00645710","publication_url":"https://clinicaltrials.gov/study/NCT00645710","title":"A Phase I/II Trial of Radioimmunotherapy (Y-90 cT84.66), Gemcitabine and Hepatic Arterial Infusion of Fudr for Metastatic Colorectal Carcinoma to the Liver","has_exemption":false,"start_date":"2005-02-11","completion_date":"2018-02-07","has_results":true,"results_due":true,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01216176","publication_url":"https://clinicaltrials.gov/study/NCT01216176","title":"A Phase I Pharmacokinetic and Randomized Phase II Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer","has_exemption":false,"start_date":"2008-10-21","completion_date":"2018-02-07","has_results":true,"results_due":true,"sponsor_name":"Joyce Marie Slingerland, MD","sponsor_slug":"joyce-marie-slingerland-md","status":"reported-late","is_pact":true,"days_late":84},{"registry_id":"NCT01774487","publication_url":"https://clinicaltrials.gov/study/NCT01774487","title":"A Phase II Trial of Pentoxifylline in Newly-Diagnosed Biliary Atresia","has_exemption":false,"start_date":"2013-02-04","completion_date":"2018-02-07","has_results":true,"results_due":true,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"reported-late","is_pact":true,"days_late":1570},{"registry_id":"NCT01994889","publication_url":"https://clinicaltrials.gov/study/NCT01994889","title":"A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)","has_exemption":false,"start_date":"2013-12-09","completion_date":"2018-02-07","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02227277","publication_url":"https://clinicaltrials.gov/study/NCT02227277","title":"Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy","has_exemption":false,"start_date":"2015-02-11","completion_date":"2018-02-07","has_results":false,"results_due":true,"sponsor_name":"The Wistar Institute","sponsor_slug":"the-wistar-institute","status":"overdue","is_pact":true,"days_late":2639},{"registry_id":"NCT03421691","publication_url":"https://clinicaltrials.gov/study/NCT03421691","title":"A Single-Center Open-Label Study of 1064 nm for Nonablative Skin Rejuvenation","has_exemption":false,"start_date":"2016-03-15","completion_date":"2018-02-07","has_results":true,"results_due":true,"sponsor_name":"Cutera Inc.","sponsor_slug":"cutera-inc","status":"reported-late","is_pact":true,"days_late":1646},{"registry_id":"NCT03074331","publication_url":"https://clinicaltrials.gov/study/NCT03074331","title":"A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Subjects With Chronic Hepatitis C Virus (HCV) Infection","has_exemption":false,"start_date":"2017-03-23","completion_date":"2018-02-07","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported-late","is_pact":false,"days_late":18},{"registry_id":"NCT01681810","publication_url":"https://clinicaltrials.gov/study/NCT01681810","title":"An Open-Label Study of Oral Nitrite in Adults With Metabolic Syndrome and Hypertension","has_exemption":false,"start_date":"2012-10-31","completion_date":"2018-02-08","has_results":true,"results_due":true,"sponsor_name":"Gladwin, Mark, MD","sponsor_slug":"gladwin-mark-md","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01745120","publication_url":"https://clinicaltrials.gov/study/NCT01745120","title":"A Phase 1/2 Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects With β-Thalassemia Major by Transplantation of Autologous CD34+ Cells Transduced Ex Vivo With a Lentiviral βA-T87Q-Globin Vector (LentiGlobin® BB305 Drug Product)","has_exemption":false,"start_date":"2013-08-31","completion_date":"2018-02-08","has_results":true,"results_due":true,"sponsor_name":"Genetix Biotherapeutics Inc.","sponsor_slug":"genetix-biotherapeutics-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02515669","publication_url":"https://clinicaltrials.gov/study/NCT02515669","title":"A Multi-Site, Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7239361 (BMS-986089) in Ambulatory Boys With Duchenne Muscular Dystrophy","has_exemption":false,"start_date":"2015-12-02","completion_date":"2018-02-08","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02432196","publication_url":"https://clinicaltrials.gov/study/NCT02432196","title":"Safety and Performance Study of the Harpoon Medical Transapical Suturing Device (TSD-5) in Subjects With Degenerative Mitral Regurgitation - CE Mark Study for the Harpoon Medical Device in Poland","has_exemption":false,"start_date":"2015-12-11","completion_date":"2018-02-08","has_results":true,"results_due":true,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"reported-late","is_pact":true,"days_late":227},{"registry_id":"NCT02324699","publication_url":"https://clinicaltrials.gov/study/NCT02324699","title":"Corticosteroids as Co-Induction Agents With Vedolizumab in Crohn's Disease: a Double-blind Placebo Controlled Randomized Trial","has_exemption":false,"start_date":"2016-04-30","completion_date":"2018-02-08","has_results":true,"results_due":true,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"reported-late","is_pact":true,"days_late":55},{"registry_id":"NCT02862548","publication_url":"https://clinicaltrials.gov/study/NCT02862548","title":"A Phase 2, Randomized, Open Label Study to Evaluate the Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Subjects With Chronic HBV Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant","has_exemption":false,"start_date":"2016-09-16","completion_date":"2018-02-08","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03015259","publication_url":"https://clinicaltrials.gov/study/NCT03015259","title":"Randomized, Single Blind, Parallel Group, Placebo Controlled, Multidose Study Comparing the Therapeutic Equivalence of a 3M Budesonide/Formoterol Fumarate Inhaler and a Symbicort® Reference Inhaler in Adult Subjects With Asthma","has_exemption":true,"start_date":"2016-12-29","completion_date":"2018-02-08","has_results":true,"results_due":true,"sponsor_name":"Kindeva Drug Delivery","sponsor_slug":"kindeva-drug-delivery","status":"reported-late","is_pact":true,"days_late":490},{"registry_id":"NCT03061734","publication_url":"https://clinicaltrials.gov/study/NCT03061734","title":"A Clinical Trial to Assess a Single Dose of Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine","has_exemption":false,"start_date":"2017-02-18","completion_date":"2018-02-08","has_results":false,"results_due":true,"sponsor_name":"Allodynic Therapeutics, Inc","sponsor_slug":"allodynic-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":1820},{"registry_id":"NCT06245902","publication_url":"https://clinicaltrials.gov/study/NCT06245902","title":"A Clinical Trial to Assess a Single Dose of Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine","has_exemption":false,"start_date":"2017-02-18","completion_date":"2018-02-08","has_results":false,"results_due":true,"sponsor_name":"Allodynic Therapeutics, Inc","sponsor_slug":"allodynic-therapeutics-inc","status":"overdue","is_pact":false,"days_late":2638},{"registry_id":"NCT03075891","publication_url":"https://clinicaltrials.gov/study/NCT03075891","title":"Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea","has_exemption":false,"start_date":"2017-07-05","completion_date":"2018-02-08","has_results":true,"results_due":true,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"reported-late","is_pact":false,"days_late":220},{"registry_id":"NCT02352948","publication_url":"https://clinicaltrials.gov/study/NCT02352948","title":"A Phase III, Open Label, Randomised, Multi-centre, International Study of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB-IV) Who Have Received at Least Two Prior Systemic Treatment Regimens Including One Platinum Based Chemotherapy Regimen and Do Not Have Known EGFR TK Activating Mutations or ALK Rearrangements (ARCTIC).","has_exemption":false,"start_date":"2015-01-13","completion_date":"2018-02-09","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02819557","publication_url":"https://clinicaltrials.gov/study/NCT02819557","title":"A Phase 2 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Ataluren (PTC124®) in Patients Aged ≥2 to <5 Years Old With Nonsense Mutation Dystrophinopathy","has_exemption":true,"start_date":"2016-06-09","completion_date":"2018-02-09","has_results":true,"results_due":true,"sponsor_name":"PTC Therapeutics","sponsor_slug":"ptc-therapeutics","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02982720","publication_url":"https://clinicaltrials.gov/study/NCT02982720","title":"A Phase II Multi-center Study Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and Sylatron (Peginterferon Alfa-2b) HCRN:GI16-263","has_exemption":false,"start_date":"2017-07-05","completion_date":"2018-02-09","has_results":true,"results_due":true,"sponsor_name":"Aiwu Ruth He, MD","sponsor_slug":"aiwu-ruth-he-md","status":"reported-late","is_pact":false,"days_late":96},{"registry_id":"NCT03388138","publication_url":"https://clinicaltrials.gov/study/NCT03388138","title":"Clinical Evaluation of Etafilcon A With Ketotifen","has_exemption":true,"start_date":"2017-12-06","completion_date":"2018-02-09","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02175225","publication_url":"https://clinicaltrials.gov/study/NCT02175225","title":"Study of Deferoxamine Mesylate in Intracerebral Hemorrhage","has_exemption":false,"start_date":"2014-10-31","completion_date":"2018-02-10","has_results":true,"results_due":true,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported-late","is_pact":true,"days_late":87},{"registry_id":"NCT02581930","publication_url":"https://clinicaltrials.gov/study/NCT02581930","title":"A Phase 2 Study of Ibrutinib (PCI-32765) in Refractory Distant Metastatic Cutaneous Melanoma: Correlation of Biomarkers With Response and Resistance","has_exemption":false,"start_date":"2016-08-17","completion_date":"2018-02-10","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":52},{"registry_id":"NCT02062008","publication_url":"https://clinicaltrials.gov/study/NCT02062008","title":"Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications","has_exemption":false,"start_date":"2016-12-31","completion_date":"2018-02-10","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported-late","is_pact":true,"days_late":830},{"registry_id":"NCT03300024","publication_url":"https://clinicaltrials.gov/study/NCT03300024","title":"A Prospective Randomized Study of Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access","has_exemption":false,"start_date":"2015-02-01","completion_date":"2018-02-12","has_results":true,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"reported-late","is_pact":true,"days_late":45},{"registry_id":"NCT02397473","publication_url":"https://clinicaltrials.gov/study/NCT02397473","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Cluster Headache","has_exemption":false,"start_date":"2015-05-22","completion_date":"2018-02-12","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02532543","publication_url":"https://clinicaltrials.gov/study/NCT02532543","title":"Prospective, Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials (SYMBIOS CORTICAL-CANCELLOUS GRANULE MIX; SYMBIOS OSTEOGRAF LD-300; OSTEOGRAF/N-300) Following Tooth Extraction","has_exemption":false,"start_date":"2016-04-30","completion_date":"2018-02-12","has_results":true,"results_due":true,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"reported-late","is_pact":true,"days_late":262},{"registry_id":"NCT02915705","publication_url":"https://clinicaltrials.gov/study/NCT02915705","title":"A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)","has_exemption":false,"start_date":"2016-09-08","completion_date":"2018-02-12","has_results":true,"results_due":true,"sponsor_name":"Kyowa Kirin, Inc.","sponsor_slug":"kyowa-kirin-inc","status":"reported-late","is_pact":true,"days_late":16},{"registry_id":"NCT03002623","publication_url":"https://clinicaltrials.gov/study/NCT03002623","title":"A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer","has_exemption":false,"start_date":"2016-12-22","completion_date":"2018-02-12","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03211117","publication_url":"https://clinicaltrials.gov/study/NCT03211117","title":"Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer","has_exemption":false,"start_date":"2017-08-14","completion_date":"2018-02-12","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported-late","is_pact":false,"days_late":146},{"registry_id":"NCT03365934","publication_url":"https://clinicaltrials.gov/study/NCT03365934","title":"Randomized, Exploratory Study to Evaluate Changes to Skin Microbiome With Tape-stripped Wounds","has_exemption":false,"start_date":"2017-11-20","completion_date":"2018-02-12","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Consumer Inc. (J&JCI)","sponsor_slug":"johnson-johnson-consumer-inc-jjci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03435224","publication_url":"https://clinicaltrials.gov/study/NCT03435224","title":"Desaturation Validation of INVSENSOR00012","has_exemption":true,"start_date":"2018-01-17","completion_date":"2018-02-12","has_results":true,"results_due":true,"sponsor_name":"Masimo Corporation","sponsor_slug":"masimo-corporation","status":"reported-late","is_pact":false,"days_late":21},{"registry_id":"NCT01208974","publication_url":"https://clinicaltrials.gov/study/NCT01208974","title":"A Phase I Trial Assessing the Safety and Feasibility of Prophylactic Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Immediate Reconstruction in Patients With In-Situ or Invasive Breast Cancer","has_exemption":false,"start_date":"2010-03-16","completion_date":"2018-02-13","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported-late","is_pact":true,"days_late":1006},{"registry_id":"NCT01532089","publication_url":"https://clinicaltrials.gov/study/NCT01532089","title":"A Randomized Phase II Trial of Erlotinib Alone or in Combination With Bevacizumab in Patients With Non-Small Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations","has_exemption":false,"start_date":"2012-03-16","completion_date":"2018-02-13","has_results":true,"results_due":true,"sponsor_name":"Academic and Community Cancer Research United","sponsor_slug":"academic-and-community-cancer-research-united","status":"reported-late","is_pact":true,"days_late":299},{"registry_id":"NCT03174925","publication_url":"https://clinicaltrials.gov/study/NCT03174925","title":"Elastography in Thyroid Nodule Evaluation","has_exemption":false,"start_date":"2014-01-24","completion_date":"2018-02-13","has_results":true,"results_due":true,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"reported-late","is_pact":true,"days_late":825},{"registry_id":"NCT02996682","publication_url":"https://clinicaltrials.gov/study/NCT02996682","title":"A Multicenter, Randomized, Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Subjects With Chronic HCV Infection and Decompensated Cirrhosis","has_exemption":false,"start_date":"2016-12-26","completion_date":"2018-02-13","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02864082","publication_url":"https://clinicaltrials.gov/study/NCT02864082","title":"A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis","has_exemption":true,"start_date":"2017-03-08","completion_date":"2018-02-13","has_results":true,"results_due":true,"sponsor_name":"Patagonia Pharmaceuticals, LLC","sponsor_slug":"patagonia-pharmaceuticals-llc","status":"reported-late","is_pact":false,"days_late":102},{"registry_id":"NCT03090256","publication_url":"https://clinicaltrials.gov/study/NCT03090256","title":"Clinical Investigation of the AcrySof® IQ PanOptix™ IOL Model TFNT00","has_exemption":true,"start_date":"2017-04-11","completion_date":"2018-02-13","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03210740","publication_url":"https://clinicaltrials.gov/study/NCT03210740","title":"A Phase 2, Single-Center, Randomized, Double- Blind, Parallel-Group, Vehicle-Controlled Study Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK) Lesions","has_exemption":true,"start_date":"2017-06-06","completion_date":"2018-02-13","has_results":false,"results_due":true,"sponsor_name":"AmDerma","sponsor_slug":"amderma","status":"overdue","is_pact":false,"days_late":1902},{"registry_id":"NCT03216226","publication_url":"https://clinicaltrials.gov/study/NCT03216226","title":"A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)","has_exemption":true,"start_date":"2017-06-28","completion_date":"2018-02-13","has_results":true,"results_due":true,"sponsor_name":"Zealand Pharma","sponsor_slug":"zealand-pharma","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03245463","publication_url":"https://clinicaltrials.gov/study/NCT03245463","title":"Evaluation of Different Methods of Teaching Self-management Strategies to Patients With Symptomatic Knee Osteoarthritis","has_exemption":false,"start_date":"2017-08-09","completion_date":"2018-02-13","has_results":true,"results_due":true,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"reported-late","is_pact":false,"days_late":177},{"registry_id":"NCT02178709","publication_url":"https://clinicaltrials.gov/study/NCT02178709","title":"A Phase II Study of Neoadjuvant FOLFIRINOX in Patients With Resectable Pancreatic Ductal Adenocarcinoma With Tissue Collection","has_exemption":false,"start_date":"2014-06-03","completion_date":"2018-02-14","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":true,"days_late":336},{"registry_id":"NCT02267226","publication_url":"https://clinicaltrials.gov/study/NCT02267226","title":"Prospective, Open-label, Uncontrolled, Phase III Study to Assess the Efficacy and Safety of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery in Subjects With Congenital Fibrinogen Deficiency","has_exemption":false,"start_date":"2014-09-30","completion_date":"2018-02-14","has_results":true,"results_due":true,"sponsor_name":"Octapharma","sponsor_slug":"octapharma","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02955784","publication_url":"https://clinicaltrials.gov/study/NCT02955784","title":"Sinasprite: A Pilot Feasibility Study of a Casual Game for Primary Care Patients With Mild Stress, Anxiety or Depression","has_exemption":false,"start_date":"2015-01-22","completion_date":"2018-02-14","has_results":false,"results_due":true,"sponsor_name":"Madigan Army Medical Center","sponsor_slug":"madigan-army-medical-center","status":"reported-late","is_pact":true,"days_late":2178},{"registry_id":"NCT02255357","publication_url":"https://clinicaltrials.gov/study/NCT02255357","title":"Investigation of the Effect of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients","has_exemption":false,"start_date":"2015-03-31","completion_date":"2018-02-14","has_results":true,"results_due":true,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"reported-late","is_pact":true,"days_late":176},{"registry_id":"NCT02428296","publication_url":"https://clinicaltrials.gov/study/NCT02428296","title":"Nonrandomized Open Label Pilot Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation","has_exemption":false,"start_date":"2015-04-23","completion_date":"2018-02-14","has_results":true,"results_due":true,"sponsor_name":"National Human Genome Research Institute (NHGRI)","sponsor_slug":"national-human-genome-research-institute-nhgri","status":"reported-late","is_pact":true,"days_late":273},{"registry_id":"NCT02447302","publication_url":"https://clinicaltrials.gov/study/NCT02447302","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of APD334 in Patients With Moderately to Severely Active Ulcerative Colitis","has_exemption":true,"start_date":"2015-10-15","completion_date":"2018-02-14","has_results":true,"results_due":true,"sponsor_name":"Arena Pharmaceuticals","sponsor_slug":"arena-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02691494","publication_url":"https://clinicaltrials.gov/study/NCT02691494","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women","has_exemption":true,"start_date":"2016-02-03","completion_date":"2018-02-14","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03212209","publication_url":"https://clinicaltrials.gov/study/NCT03212209","title":"A Crossover Study Comparing Fixed Continuous Airway Positive Pressure, FLEX- PLUS and Sensawake Modalities for OSA Treatment","has_exemption":false,"start_date":"2017-04-28","completion_date":"2018-02-14","has_results":false,"results_due":true,"sponsor_name":"Associação Fundo de Incentivo à Pesquisa","sponsor_slug":"associacao-fundo-de-incentivo-a-pesquisa","status":"overdue","is_pact":false,"days_late":2632},{"registry_id":"NCT03431441","publication_url":"https://clinicaltrials.gov/study/NCT03431441","title":"Clinical Evaluation of 2-Week Reusable ACUVUE 2 Vivid Style","has_exemption":false,"start_date":"2018-01-16","completion_date":"2018-02-14","has_results":true,"results_due":true,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03440619","publication_url":"https://clinicaltrials.gov/study/NCT03440619","title":"INVSENSOR00013 Respiratory Rate Clinical Performance Study","has_exemption":false,"start_date":"2018-02-06","completion_date":"2018-02-14","has_results":true,"results_due":true,"sponsor_name":"Masimo Corporation","sponsor_slug":"masimo-corporation","status":"reported-late","is_pact":false,"days_late":11},{"registry_id":"NCT01711541","publication_url":"https://clinicaltrials.gov/study/NCT01711541","title":"Carboplatin-Paclitaxel Induction Chemotherapy and ABT-888 (Veliparib) - a Phase 1/Randomized Phase 2 Study in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck","has_exemption":false,"start_date":"2012-10-22","completion_date":"2018-02-15","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported-late","is_pact":true,"days_late":33},{"registry_id":"NCT02138253","publication_url":"https://clinicaltrials.gov/study/NCT02138253","title":"A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy","has_exemption":false,"start_date":"2014-05-31","completion_date":"2018-02-15","has_results":true,"results_due":true,"sponsor_name":"Conatus Pharmaceuticals Inc.","sponsor_slug":"conatus-pharmaceuticals-inc","status":"reported-late","is_pact":true,"days_late":76},{"registry_id":"NCT02313909","publication_url":"https://clinicaltrials.gov/study/NCT02313909","title":"Multicenter, Randomized, Double-blind, Double-dummy, Active-comparator, Event-driven, Superiority Phase III Study of Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With a Recent Embolic Stroke of Undetermined Source (ESUS), Comparing Rivaroxaban 15 mg Once Daily With Aspirin 100 mg","has_exemption":false,"start_date":"2014-12-23","completion_date":"2018-02-15","has_results":true,"results_due":true,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02730169","publication_url":"https://clinicaltrials.gov/study/NCT02730169","title":"A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism","has_exemption":false,"start_date":"2016-05-12","completion_date":"2018-02-15","has_results":true,"results_due":true,"sponsor_name":"Mereo BioPharma","sponsor_slug":"mereo-biopharma","status":"reported-late","is_pact":true,"days_late":571},{"registry_id":"NCT01277744","publication_url":"https://clinicaltrials.gov/study/NCT01277744","title":"A Phase II Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor and Other Non-Carcinomas","has_exemption":false,"start_date":"2011-05-09","completion_date":"2018-02-16","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported-late","is_pact":true,"days_late":208},{"registry_id":"NCT02018107","publication_url":"https://clinicaltrials.gov/study/NCT02018107","title":"PET/CT-Guided Liver Tumor Ablation: Intraprocedural Assessment of Results Using Ammonia Perfusion PET","has_exemption":false,"start_date":"2014-01-31","completion_date":"2018-02-16","has_results":true,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported-late","is_pact":true,"days_late":331},{"registry_id":"NCT02410382","publication_url":"https://clinicaltrials.gov/study/NCT02410382","title":"A Phase II Randomized Study of Short-Term Dexamethasone Versus Placebo for Fatigue in Patients Receiving Radiation Alone or Radiation and Chemotherapy for the Treatment of Head and Neck and Non-Small Cell Lung Cancers","has_exemption":false,"start_date":"2014-08-27","completion_date":"2018-02-16","has_results":true,"results_due":true,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"reported-late","is_pact":true,"days_late":41},{"registry_id":"NCT02711553","publication_url":"https://clinicaltrials.gov/study/NCT02711553","title":"Randomized, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment in Patients With Advanced or Metastatic Biliary Tract Cancer","has_exemption":true,"start_date":"2016-05-19","completion_date":"2018-02-16","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02854631","publication_url":"https://clinicaltrials.gov/study/NCT02854631","title":"A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination With Prednisolone Versus Prednisolone Alone in Subjects With Severe Alcoholic Hepatitis (AH)","has_exemption":false,"start_date":"2016-09-01","completion_date":"2018-02-16","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03320434","publication_url":"https://clinicaltrials.gov/study/NCT03320434","title":"A Single-Center, Randomized, Double-Masked, Vehicle and Active-Controlled, Dose-Ranging Phase 2 Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model (Ora-CAC®)","has_exemption":true,"start_date":"2017-10-13","completion_date":"2018-02-16","has_results":true,"results_due":true,"sponsor_name":"ORA, Inc.","sponsor_slug":"ora-inc","status":"reported-late","is_pact":false,"days_late":510},{"registry_id":"NCT03349632","publication_url":"https://clinicaltrials.gov/study/NCT03349632","title":"Clinical Comparison of 4 Daily Disposable Soft Contact Lenses","has_exemption":false,"start_date":"2018-01-10","completion_date":"2018-02-16","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02527434","publication_url":"https://clinicaltrials.gov/study/NCT02527434","title":"A Phase II, Multi-Center, Open-Label Study of Tremelimumab Monotherapy in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2015-11-02","completion_date":"2018-02-17","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02763254","publication_url":"https://clinicaltrials.gov/study/NCT02763254","title":"A Phase 2 Open Label Study to Investigate the Safety and Clinical Activity of Autologous EBV-specific T Cells (CMD-003) for the Treatment of Patients With EBV Positive Lymphomas","has_exemption":false,"start_date":"2016-11-30","completion_date":"2018-02-17","has_results":true,"results_due":true,"sponsor_name":"Cell Medica Ltd","sponsor_slug":"cell-medica-ltd","status":"reported-late","is_pact":true,"days_late":2},{"registry_id":"NCT03007966","publication_url":"https://clinicaltrials.gov/study/NCT03007966","title":"Ilioinguinal/Iliohypogastric vs. Quadratus Lumborum Nerve Blockade for Elective Open Inguinal Herniorrhaphy","has_exemption":false,"start_date":"2017-01-30","completion_date":"2018-02-17","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":false,"days_late":227},{"registry_id":"NCT00777491","publication_url":"https://clinicaltrials.gov/study/NCT00777491","title":"A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy","has_exemption":false,"start_date":"2008-12-31","completion_date":"2018-02-18","has_results":true,"results_due":true,"sponsor_name":"Radiation Therapy Oncology Group","sponsor_slug":"radiation-therapy-oncology-group","status":"reported-late","is_pact":true,"days_late":102},{"registry_id":"NCT02475655","publication_url":"https://clinicaltrials.gov/study/NCT02475655","title":"A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults","has_exemption":false,"start_date":"2016-05-16","completion_date":"2018-02-18","has_results":true,"results_due":true,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02247804","publication_url":"https://clinicaltrials.gov/study/NCT02247804","title":"The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension","has_exemption":true,"start_date":"2014-12-15","completion_date":"2018-02-19","has_results":true,"results_due":true,"sponsor_name":"Allergan","sponsor_slug":"allergan","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02491359","publication_url":"https://clinicaltrials.gov/study/NCT02491359","title":"Carfilzomib for Treatment of Chronic Graft vs. Host Disease","has_exemption":false,"start_date":"2015-11-12","completion_date":"2018-02-19","has_results":true,"results_due":true,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02457195","publication_url":"https://clinicaltrials.gov/study/NCT02457195","title":"Preoperative Use of Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting (PONV) in Patients With History of Severe PONV - Open Label, Prospective, Pilot Study","has_exemption":false,"start_date":"2016-02-29","completion_date":"2018-02-19","has_results":true,"results_due":true,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02003898","publication_url":"https://clinicaltrials.gov/study/NCT02003898","title":"Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data","has_exemption":false,"start_date":"2013-11-26","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"Medtronic MiniMed, Inc.","sponsor_slug":"medtronic-minimed-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03262233","publication_url":"https://clinicaltrials.gov/study/NCT03262233","title":"Clinical Relevance of Stress Neuroadaptation in Tobacco Dependence","has_exemption":false,"start_date":"2015-04-01","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported-late","is_pact":true,"days_late":9},{"registry_id":"NCT02378883","publication_url":"https://clinicaltrials.gov/study/NCT02378883","title":"Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study","has_exemption":false,"start_date":"2015-05-18","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"Medtronic Neurovascular Clinical Affairs","sponsor_slug":"medtronic-neurovascular-clinical-affairs","status":"reported-late","is_pact":true,"days_late":9},{"registry_id":"NCT02465515","publication_url":"https://clinicaltrials.gov/study/NCT02465515","title":"A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2015-07-01","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02615509","publication_url":"https://clinicaltrials.gov/study/NCT02615509","title":"Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography","has_exemption":false,"start_date":"2016-01-31","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"Philips Digital Mammography Sweden AB","sponsor_slug":"philips-digital-mammography-sweden-ab","status":"reported-late","is_pact":true,"days_late":428},{"registry_id":"NCT02661217","publication_url":"https://clinicaltrials.gov/study/NCT02661217","title":"A Multicenter, Randomized, Open Label, Parallel Group Study Comparing Pre-discharge and posT-discharge tReatment Initiation With LCZ696 in heArt Failure patieNtS With Reduced ejectIon-fracTion hospItalized for an Acute decOmpensation eveNt (ADHF)","has_exemption":true,"start_date":"2016-02-12","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03069365","publication_url":"https://clinicaltrials.gov/study/NCT03069365","title":"A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection (EXPEDITION-5)","has_exemption":false,"start_date":"2017-03-28","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03137407","publication_url":"https://clinicaltrials.gov/study/NCT03137407","title":"A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis","has_exemption":true,"start_date":"2017-06-12","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"Revance Therapeutics, Inc.","sponsor_slug":"revance-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":832},{"registry_id":"NCT03233737","publication_url":"https://clinicaltrials.gov/study/NCT03233737","title":"A Double-blind, Cross-over, Incomplete Factorial Study to Assess the Local Anesthetic Efficacy and Safety of CTY-5339 Anesthetic Spray (CTY-5339A) When Applied to the Gingival Mucosal Tissue in Normal Volunteers","has_exemption":false,"start_date":"2017-06-15","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"Cetylite Industries","sponsor_slug":"cetylite-industries","status":"reported-late","is_pact":false,"days_late":105},{"registry_id":"NCT03349437","publication_url":"https://clinicaltrials.gov/study/NCT03349437","title":"Pilot Study to Assess the Effect of Providing Intermittent Positive Airway Pressure in COPD Patients in Order to Relieve Their Exertion Related Shortness of Breath","has_exemption":false,"start_date":"2017-11-06","completion_date":"2018-02-20","has_results":true,"results_due":true,"sponsor_name":"Philips Respironics","sponsor_slug":"philips-respironics","status":"reported-late","is_pact":false,"days_late":33},{"registry_id":"NCT01760252","publication_url":"https://clinicaltrials.gov/study/NCT01760252","title":"Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Resectable, Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Protocol","has_exemption":false,"start_date":"2011-12-31","completion_date":"2018-02-21","has_results":false,"results_due":true,"sponsor_name":"Beth Israel Medical Center","sponsor_slug":"beth-israel-medical-center","status":"overdue","is_pact":true,"days_late":2625},{"registry_id":"NCT01829295","publication_url":"https://clinicaltrials.gov/study/NCT01829295","title":"First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial","has_exemption":false,"start_date":"2013-08-31","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported-late","is_pact":true,"days_late":41},{"registry_id":"NCT01988584","publication_url":"https://clinicaltrials.gov/study/NCT01988584","title":"Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP)","has_exemption":true,"start_date":"2013-11-30","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01903447","publication_url":"https://clinicaltrials.gov/study/NCT01903447","title":"Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment","has_exemption":false,"start_date":"2013-12-13","completion_date":"2018-02-21","has_results":false,"results_due":true,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"reported-late","is_pact":true,"days_late":312},{"registry_id":"NCT02180217","publication_url":"https://clinicaltrials.gov/study/NCT02180217","title":"Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease","has_exemption":true,"start_date":"2014-10-06","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02300987","publication_url":"https://clinicaltrials.gov/study/NCT02300987","title":"A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression","has_exemption":false,"start_date":"2015-02-26","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02238847","publication_url":"https://clinicaltrials.gov/study/NCT02238847","title":"Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer","has_exemption":false,"start_date":"2015-03-24","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"reported-late","is_pact":true,"days_late":154},{"registry_id":"NCT02422290","publication_url":"https://clinicaltrials.gov/study/NCT02422290","title":"Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)","has_exemption":false,"start_date":"2015-03-31","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"reported-late","is_pact":true,"days_late":337},{"registry_id":"NCT02256111","publication_url":"https://clinicaltrials.gov/study/NCT02256111","title":"EXTEND: Safety and Efficacy of EXercise Training in Men Receiving ENzalutamide in Combination With Conventional Androgen Deprivation Therapy for Hormone Naïve Prostate Cancer","has_exemption":false,"start_date":"2015-05-13","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02608476","publication_url":"https://clinicaltrials.gov/study/NCT02608476","title":"A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris","has_exemption":true,"start_date":"2015-11-16","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"Cassiopea SpA","sponsor_slug":"cassiopea-spa","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02616783","publication_url":"https://clinicaltrials.gov/study/NCT02616783","title":"A Phase 3b, Randomized, Open-Label Study to Evaluate Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Subjects Aged ≥ 60 Years","has_exemption":false,"start_date":"2015-12-22","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02666664","publication_url":"https://clinicaltrials.gov/study/NCT02666664","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Long-term Safety and Tolerability Study of ETC-1002 in Patients With Hyperlipidemia at High Cardiovascular Risk Who Are Not Adequately Controlled by Their Lipid-Modifying Therapy","has_exemption":true,"start_date":"2016-01-21","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"Esperion Therapeutics, Inc.","sponsor_slug":"esperion-therapeutics-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03305770","publication_url":"https://clinicaltrials.gov/study/NCT03305770","title":"DD T2 Daily Disposable Registration Trial","has_exemption":false,"start_date":"2017-10-12","completion_date":"2018-02-21","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT01273610","publication_url":"https://clinicaltrials.gov/study/NCT01273610","title":"Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2011-04-20","completion_date":"2018-02-22","has_results":true,"results_due":true,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"reported-late","is_pact":true,"days_late":949},{"registry_id":"NCT02039726","publication_url":"https://clinicaltrials.gov/study/NCT02039726","title":"A Phase 3 Open-label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects With Tyrosine Kinase 3 - Internal Tandem Duplication (FLT3-ITD) Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed After First-line Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation","has_exemption":false,"start_date":"2014-05-31","completion_date":"2018-02-22","has_results":true,"results_due":true,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"reported-late","is_pact":true,"days_late":215},{"registry_id":"NCT02397096","publication_url":"https://clinicaltrials.gov/study/NCT02397096","title":"A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs)","has_exemption":false,"start_date":"2015-06-09","completion_date":"2018-02-22","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03052725","publication_url":"https://clinicaltrials.gov/study/NCT03052725","title":"An Open-Label Extension Study of Reslizumab 110-mg Fixed, Subcutaneous Dosing in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma","has_exemption":false,"start_date":"2017-03-10","completion_date":"2018-02-22","has_results":true,"results_due":true,"sponsor_name":"Teva Branded Pharmaceutical Products, R&D Inc.","sponsor_slug":"teva-branded-pharmaceutical-products-rd-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03365154","publication_url":"https://clinicaltrials.gov/study/NCT03365154","title":"Feasibility Clinical Trial of the Cardio Flow FreedomFlow Orbital Atherectomy System to Treat Peripheral Artery Disease","has_exemption":true,"start_date":"2018-01-25","completion_date":"2018-02-22","has_results":true,"results_due":true,"sponsor_name":"Cardio Flow, Inc.","sponsor_slug":"cardio-flow-inc","status":"reported-late","is_pact":false,"days_late":37},{"registry_id":"NCT00411632","publication_url":"https://clinicaltrials.gov/study/NCT00411632","title":"A Phase II Study of Erlotinib (Tarceva) in Combination With Bexarotene (Targretin) in Chemorefractory Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2006-11-29","completion_date":"2018-02-23","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported-late","is_pact":true,"days_late":192},{"registry_id":"NCT01778556","publication_url":"https://clinicaltrials.gov/study/NCT01778556","title":"Short Term Effects of Leptin Withdrawal or Initiation in Lipodystrophy Independent of Energy Intake","has_exemption":false,"start_date":"2013-01-26","completion_date":"2018-02-23","has_results":true,"results_due":true,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"reported-late","is_pact":true,"days_late":121},{"registry_id":"NCT02083354","publication_url":"https://clinicaltrials.gov/study/NCT02083354","title":"An Open-Label, Multi-Center Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma","has_exemption":true,"start_date":"2014-03-18","completion_date":"2018-02-23","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01976728","publication_url":"https://clinicaltrials.gov/study/NCT01976728","title":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism","has_exemption":true,"start_date":"2014-04-01","completion_date":"2018-02-23","has_results":true,"results_due":true,"sponsor_name":"Ferring Pharmaceuticals","sponsor_slug":"ferring-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02124759","publication_url":"https://clinicaltrials.gov/study/NCT02124759","title":"Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)","has_exemption":false,"start_date":"2014-04-02","completion_date":"2018-02-23","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"reported-late","is_pact":true,"days_late":534},{"registry_id":"NCT02270736","publication_url":"https://clinicaltrials.gov/study/NCT02270736","title":"Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Children and Adolescents (2-17 Years) With Chronic Troublesome Sialorrhea Associated With Neurological Disorders, and/or Intellectual Disability","has_exemption":true,"start_date":"2015-02-09","completion_date":"2018-02-23","has_results":true,"results_due":true,"sponsor_name":"Merz Pharmaceuticals GmbH","sponsor_slug":"merz-pharmaceuticals-gmbh","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02460679","publication_url":"https://clinicaltrials.gov/study/NCT02460679","title":"A Phase 2A Safety and Biomarker Study of EPI-589 in Subjects With Amyotrophic Lateral Sclerosis","has_exemption":false,"start_date":"2016-01-14","completion_date":"2018-02-23","has_results":true,"results_due":true,"sponsor_name":"PTC Therapeutics","sponsor_slug":"ptc-therapeutics","status":"reported-late","is_pact":true,"days_late":550},{"registry_id":"NCT03111550","publication_url":"https://clinicaltrials.gov/study/NCT03111550","title":"Clinical Investigation of the TECNIS Next-Generation Intraocular Lens","has_exemption":true,"start_date":"2017-05-10","completion_date":"2018-02-23","has_results":true,"results_due":true,"sponsor_name":"Abbott Medical Optics","sponsor_slug":"abbott-medical-optics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02662036","publication_url":"https://clinicaltrials.gov/study/NCT02662036","title":"A Prospective Trial to Assess Analgesic Efficacy of Liposomal Bupivacaine vs. Bupivacaine HCL as a Tap Block After Abdominally Based Autologous Breast Reconstruction","has_exemption":false,"start_date":"2016-02-29","completion_date":"2018-02-26","has_results":true,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT00940602","publication_url":"https://clinicaltrials.gov/study/NCT00940602","title":"A Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of Deferasirox in Patients With Myelodysplastic Syndromes (Low/Int-1 Risk) and Transfusional Iron Overload","has_exemption":false,"start_date":"2010-03-22","completion_date":"2018-02-27","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01683331","publication_url":"https://clinicaltrials.gov/study/NCT01683331","title":"A Clinical Trial to Prevent New Onset Diabetes After Transplantation","has_exemption":false,"start_date":"2012-08-31","completion_date":"2018-02-27","has_results":true,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02039505","publication_url":"https://clinicaltrials.gov/study/NCT02039505","title":"Phase III, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intravenous MLN0002 (300 mg) Infusion in Induction and Maintenance Therapy in Japanese Subjects With Moderate or Severe Ulcerative Colitis","has_exemption":false,"start_date":"2014-02-04","completion_date":"2018-02-27","has_results":true,"results_due":true,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02167256","publication_url":"https://clinicaltrials.gov/study/NCT02167256","title":"A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease","has_exemption":false,"start_date":"2014-12-31","completion_date":"2018-02-27","has_results":true,"results_due":true,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"reported-late","is_pact":true,"days_late":112},{"registry_id":"NCT02419508","publication_url":"https://clinicaltrials.gov/study/NCT02419508","title":"Additive Effect of Twice Daily Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue","has_exemption":false,"start_date":"2015-08-07","completion_date":"2018-02-27","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03067272","publication_url":"https://clinicaltrials.gov/study/NCT03067272","title":"Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception","has_exemption":false,"start_date":"2017-03-15","completion_date":"2018-02-27","has_results":false,"results_due":true,"sponsor_name":"Femasys Inc.","sponsor_slug":"femasys-inc","status":"reported-late","is_pact":false,"days_late":2613},{"registry_id":"NCT03056690","publication_url":"https://clinicaltrials.gov/study/NCT03056690","title":"A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia","has_exemption":true,"start_date":"2017-03-20","completion_date":"2018-02-27","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03216902","publication_url":"https://clinicaltrials.gov/study/NCT03216902","title":"A Phase IIb, Randomized, Observer-Masked, Placebo- and Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-126 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study","has_exemption":false,"start_date":"2017-07-25","completion_date":"2018-02-27","has_results":true,"results_due":true,"sponsor_name":"Santen Inc.","sponsor_slug":"santen-inc","status":"reported-late","is_pact":false,"days_late":541},{"registry_id":"NCT00203021","publication_url":"https://clinicaltrials.gov/study/NCT00203021","title":"Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone","has_exemption":false,"start_date":"1994-03-26","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Teva Branded Pharmaceutical Products, R&D Inc.","sponsor_slug":"teva-branded-pharmaceutical-products-rd-inc","status":"reported-late","is_pact":true,"days_late":116},{"registry_id":"NCT02021032","publication_url":"https://clinicaltrials.gov/study/NCT02021032","title":"Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)","has_exemption":false,"start_date":"2006-02-28","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Medifocus, Inc.","sponsor_slug":"medifocus-inc","status":"overdue","is_pact":true,"days_late":2618},{"registry_id":"NCT00875342","publication_url":"https://clinicaltrials.gov/study/NCT00875342","title":"D-cycloserine Enhanced Imaginal ExposureTherapy for Posttraumatic Stress Disorder (PTSD)","has_exemption":true,"start_date":"2008-05-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported-late","is_pact":true,"days_late":113},{"registry_id":"NCT00761267","publication_url":"https://clinicaltrials.gov/study/NCT00761267","title":"A PROSPECTIVE, OPEN-LABEL STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY & EFFICACY OF ANIDULAFUNGIN WHEN USED TO TREAT CHILDREN WITH INVASIVE CANDIDIASIS, INCLUDING CANDIDEMIA","has_exemption":false,"start_date":"2009-02-28","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT00887536","publication_url":"https://clinicaltrials.gov/study/NCT00887536","title":"A Phase III Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer","has_exemption":false,"start_date":"2009-05-31","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"NSABP Foundation Inc","sponsor_slug":"nsabp-foundation-inc","status":"overdue","is_pact":true,"days_late":2618},{"registry_id":"NCT01107665","publication_url":"https://clinicaltrials.gov/study/NCT01107665","title":"A Phase II, Single-Arm Study of Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma","has_exemption":false,"start_date":"2010-08-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01308905","publication_url":"https://clinicaltrials.gov/study/NCT01308905","title":"Pilot Study to Determine the Utility of [18F] 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography in Monitoring Patient Response to Chemotherapy in Neuroblastoma","has_exemption":false,"start_date":"2011-02-28","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Barbara Ann Karmanos Cancer Institute","sponsor_slug":"barbara-ann-karmanos-cancer-institute","status":"reported-late","is_pact":true,"days_late":1935},{"registry_id":"NCT01330966","publication_url":"https://clinicaltrials.gov/study/NCT01330966","title":"A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma","has_exemption":false,"start_date":"2011-04-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Emerald Clinical Inc.","sponsor_slug":"emerald-clinical-inc","status":"reported-late","is_pact":true,"days_late":209},{"registry_id":"NCT03115515","publication_url":"https://clinicaltrials.gov/study/NCT03115515","title":"Randomized, Prospective Trial Comparing the Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy","has_exemption":false,"start_date":"2011-08-31","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"reported-late","is_pact":true,"days_late":1111},{"registry_id":"NCT01606787","publication_url":"https://clinicaltrials.gov/study/NCT01606787","title":"Phase 3 Trial of Intravenous Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes","has_exemption":false,"start_date":"2012-05-22","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01572922","publication_url":"https://clinicaltrials.gov/study/NCT01572922","title":"Massive Iron Deposit Assessment","has_exemption":false,"start_date":"2012-06-11","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"reported-late","is_pact":true,"days_late":1},{"registry_id":"NCT01652976","publication_url":"https://clinicaltrials.gov/study/NCT01652976","title":"Phase II Study of 5-Fluorouracil, Oxaliplatin Plus Dasatinib (FOLFOX-D) in First-line Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2012-07-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"reported-late","is_pact":true,"days_late":1},{"registry_id":"NCT01523275","publication_url":"https://clinicaltrials.gov/study/NCT01523275","title":"A Randomized Study of Mitomycin-C Application in the Endoscopic Surgical Treatment of Patients With Laryngotracheal Stenosis","has_exemption":false,"start_date":"2012-08-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported-late","is_pact":true,"days_late":35},{"registry_id":"NCT01788423","publication_url":"https://clinicaltrials.gov/study/NCT01788423","title":"Evaluating Hearing Aid Service Delivery Models","has_exemption":false,"start_date":"2012-11-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported-late","is_pact":true,"days_late":84},{"registry_id":"NCT01758523","publication_url":"https://clinicaltrials.gov/study/NCT01758523","title":"Dutasteride Treatment for the Reduction of Heavy Drinking","has_exemption":false,"start_date":"2013-01-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"UConn Health","sponsor_slug":"uconn-health","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01709721","publication_url":"https://clinicaltrials.gov/study/NCT01709721","title":"A Controlled, Two-Arm, Parallel Group, Randomized Withdrawal Study to Assess the Safety and Efficacy of Hydromorphone Hydrochloride Delivered by Intrathecal Administration Using a Programmable Implantable Pump","has_exemption":true,"start_date":"2013-02-28","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Piramal Critical Care, Ltd.","sponsor_slug":"piramal-critical-care-ltd","status":"reported-late","is_pact":true,"days_late":144},{"registry_id":"NCT01671488","publication_url":"https://clinicaltrials.gov/study/NCT01671488","title":"BrUOG 276: A Phase I/II Evaluation of ADXS11-001, Mitomycin,5-fluorouracil (5-FU) and IMRT for Anal Cancer","has_exemption":false,"start_date":"2013-02-28","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01781429","publication_url":"https://clinicaltrials.gov/study/NCT01781429","title":"Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies","has_exemption":false,"start_date":"2013-03-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"BioMed Valley Discoveries, Inc","sponsor_slug":"biomed-valley-discoveries-inc","status":"reported-late","is_pact":true,"days_late":229},{"registry_id":"NCT01854385","publication_url":"https://clinicaltrials.gov/study/NCT01854385","title":"Sumatriptan as Treatment for Moderate to Severe Post-Traumatic Headache","has_exemption":false,"start_date":"2013-06-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported-late","is_pact":true,"days_late":973},{"registry_id":"NCT01709747","publication_url":"https://clinicaltrials.gov/study/NCT01709747","title":"A Phase 3, Open-Label, Single-Arm Study To Assess The Safety Of Hydromorphone Hydrochloride Delivered By Intrathecal Administration","has_exemption":true,"start_date":"2013-06-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Piramal Critical Care, Ltd.","sponsor_slug":"piramal-critical-care-ltd","status":"reported-late","is_pact":true,"days_late":141},{"registry_id":"NCT02119442","publication_url":"https://clinicaltrials.gov/study/NCT02119442","title":"Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves","has_exemption":false,"start_date":"2013-08-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT01573442","publication_url":"https://clinicaltrials.gov/study/NCT01573442","title":"Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias","has_exemption":false,"start_date":"2013-09-10","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"reported-late","is_pact":true,"days_late":55},{"registry_id":"NCT02038569","publication_url":"https://clinicaltrials.gov/study/NCT02038569","title":"Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis","has_exemption":false,"start_date":"2014-01-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"LEO Pharma","sponsor_slug":"leo-pharma","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02202551","publication_url":"https://clinicaltrials.gov/study/NCT02202551","title":"Open-Label Safety Study of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia (LID)","has_exemption":false,"start_date":"2014-07-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Adamas Pharmaceuticals, Inc.","sponsor_slug":"adamas-pharmaceuticals-inc","status":"reported-late","is_pact":true,"days_late":496},{"registry_id":"NCT02209272","publication_url":"https://clinicaltrials.gov/study/NCT02209272","title":"Local Anesthesia for Ultrasound Guided Hip Joint Injections: A Double-Blinded Randomized Controlled Trial of Bacteriostatic Saline Versus Buffered Lidocaine","has_exemption":false,"start_date":"2014-08-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported-late","is_pact":true,"days_late":4},{"registry_id":"NCT02283463","publication_url":"https://clinicaltrials.gov/study/NCT02283463","title":"Patient Discomfort With a Novel Suction Based Cervical Retractor Compared to the Traditional Cervical Tenaculum","has_exemption":false,"start_date":"2014-09-30","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Bioceptive","sponsor_slug":"bioceptive","status":"overdue","is_pact":true,"days_late":2618},{"registry_id":"NCT02264288","publication_url":"https://clinicaltrials.gov/study/NCT02264288","title":"A Phase 2 Multicenter, Randomized, Doubleblind, Placebo-Controlled, Dose Range Finding Study to Evaluate the Efficacy and Safety of Intramuscular Injection of Human Placenta-derived Cells (Pda-002) in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease","has_exemption":false,"start_date":"2014-10-23","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Celularity Incorporated","sponsor_slug":"celularity-incorporated","status":"reported-late","is_pact":true,"days_late":1077},{"registry_id":"NCT02183792","publication_url":"https://clinicaltrials.gov/study/NCT02183792","title":"Aquaresis Utility for Hyponatremic Acute Heart Failure Study","has_exemption":false,"start_date":"2014-12-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"reported-late","is_pact":true,"days_late":63},{"registry_id":"NCT02410707","publication_url":"https://clinicaltrials.gov/study/NCT02410707","title":"Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults, a Pilot Study","has_exemption":false,"start_date":"2015-02-28","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Albert Einstein Healthcare Network","sponsor_slug":"albert-einstein-healthcare-network","status":"reported-late","is_pact":true,"days_late":320},{"registry_id":"NCT02354586","publication_url":"https://clinicaltrials.gov/study/NCT02354586","title":"A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens","has_exemption":true,"start_date":"2015-03-23","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Tesaro, Inc.","sponsor_slug":"tesaro-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02347098","publication_url":"https://clinicaltrials.gov/study/NCT02347098","title":"Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II","has_exemption":false,"start_date":"2015-03-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported-late","is_pact":true,"days_late":60},{"registry_id":"NCT02192502","publication_url":"https://clinicaltrials.gov/study/NCT02192502","title":"A Randomized Controlled Investigation of the Effects of 6% Hydroxyethylstarch 130/0.4 (Voluven) on Renal Function in Patients Having Aortic Valve Replacement With or Without Coronary Artery Bypass Grafting","has_exemption":false,"start_date":"2015-03-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"reported-late","is_pact":true,"days_late":1301},{"registry_id":"NCT02421601","publication_url":"https://clinicaltrials.gov/study/NCT02421601","title":"A Multicenter, Open-label Study of SI 6603 in Patients With Lumbar Disc Herniation (Phase III)","has_exemption":true,"start_date":"2015-03-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Seikagaku Corporation","sponsor_slug":"seikagaku-corporation","status":"reported-late","is_pact":true,"days_late":172},{"registry_id":"NCT02355886","publication_url":"https://clinicaltrials.gov/study/NCT02355886","title":"Randomized Placebo Control Trial of Perioperative Gabapentin to Reduce Total Analgesic Requirements in Patients Undergoing Radical Cystectomy","has_exemption":false,"start_date":"2015-04-22","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02351739","publication_url":"https://clinicaltrials.gov/study/NCT02351739","title":"Randomized Phase 2 Trial of ACP-196 and Pembrolizumab Immunotherapy Dual CHECKpoint Inhibition In Platinum Resistant Metastatic Urothelial Carcinoma (RAPID CHECK Study)","has_exemption":false,"start_date":"2015-04-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Acerta Pharma BV","sponsor_slug":"acerta-pharma-bv","status":"reported-late","is_pact":true,"days_late":141},{"registry_id":"NCT02407600","publication_url":"https://clinicaltrials.gov/study/NCT02407600","title":"Phase II, Double-blind, Placebo-controlled, Crossover Study Evaluating a 5HT3 Antagonist Plus Dexamethasone With or Without Fosaprepitant in Patients With Advanced NSCLC Receiving Carboplatin Based Chemotherapy","has_exemption":false,"start_date":"2015-04-30","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Ajeet Gajra","sponsor_slug":"ajeet-gajra","status":"overdue","is_pact":true,"days_late":2618},{"registry_id":"NCT02428855","publication_url":"https://clinicaltrials.gov/study/NCT02428855","title":"Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma","has_exemption":false,"start_date":"2015-04-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported-late","is_pact":true,"days_late":508},{"registry_id":"NCT02365701","publication_url":"https://clinicaltrials.gov/study/NCT02365701","title":"Double-blind, Placebo-controlled, Randomized, 4-week, Phase II Clinical Trial for Assessment of Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia","has_exemption":false,"start_date":"2015-06-30","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Dong-A ST Co., Ltd.","sponsor_slug":"dong-a-st-co-ltd","status":"overdue","is_pact":true,"days_late":2618},{"registry_id":"NCT02523235","publication_url":"https://clinicaltrials.gov/study/NCT02523235","title":"Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks","has_exemption":false,"start_date":"2015-08-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported-late","is_pact":true,"days_late":91},{"registry_id":"NCT02414841","publication_url":"https://clinicaltrials.gov/study/NCT02414841","title":"Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease","has_exemption":false,"start_date":"2015-08-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Proteon Therapeutics","sponsor_slug":"proteon-therapeutics","status":"reported-late","is_pact":true,"days_late":85},{"registry_id":"NCT02512588","publication_url":"https://clinicaltrials.gov/study/NCT02512588","title":"A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2","has_exemption":false,"start_date":"2015-09-30","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Balance Therapeutics","sponsor_slug":"balance-therapeutics","status":"overdue","is_pact":true,"days_late":2618},{"registry_id":"NCT02553135","publication_url":"https://clinicaltrials.gov/study/NCT02553135","title":"An Open Label Phase 2 Clinical Trial of Retinal Gene Therapy for Choroideremia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1)","has_exemption":false,"start_date":"2015-09-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Byron Lam","sponsor_slug":"byron-lam","status":"reported-late","is_pact":true,"days_late":122},{"registry_id":"NCT02253394","publication_url":"https://clinicaltrials.gov/study/NCT02253394","title":"The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study (The CAPS-PAH Study)","has_exemption":false,"start_date":"2015-09-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported-late","is_pact":true,"days_late":181},{"registry_id":"NCT02483078","publication_url":"https://clinicaltrials.gov/study/NCT02483078","title":"A Multi-center, Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination With Optimized Background Therapy in Treatment-Experienced HIV-1 Subjects","has_exemption":false,"start_date":"2015-10-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"CytoDyn, Inc.","sponsor_slug":"cytodyn-inc","status":"reported-late","is_pact":true,"days_late":1246},{"registry_id":"NCT02588586","publication_url":"https://clinicaltrials.gov/study/NCT02588586","title":"An Open Label, Phase 2 Study of the Safety and Antiretroviral Activity of 3BNC117 in HIV-Infected Individuals on Combination Antiretroviral Therapy","has_exemption":true,"start_date":"2015-10-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Rockefeller University","sponsor_slug":"rockefeller-university","status":"reported-late","is_pact":true,"days_late":31},{"registry_id":"NCT02610283","publication_url":"https://clinicaltrials.gov/study/NCT02610283","title":"A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery","has_exemption":true,"start_date":"2015-12-31","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Quark Pharmaceuticals","sponsor_slug":"quark-pharmaceuticals","status":"overdue","is_pact":true,"days_late":1887},{"registry_id":"NCT02605863","publication_url":"https://clinicaltrials.gov/study/NCT02605863","title":"The Effect of Androgen Deprivation Therapy With Enzalutamide on Bladder Cancer Chemoprevention","has_exemption":false,"start_date":"2016-01-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02684591","publication_url":"https://clinicaltrials.gov/study/NCT02684591","title":"Aramchol Versus Placebo in the Treatment of HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy: A Randomized, Double-blinded, Allocation-concealed, Placebo-controlled Clinical Trial","has_exemption":false,"start_date":"2016-01-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported-late","is_pact":true,"days_late":151},{"registry_id":"NCT02623803","publication_url":"https://clinicaltrials.gov/study/NCT02623803","title":"Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies","has_exemption":false,"start_date":"2016-01-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported-late","is_pact":true,"days_late":21},{"registry_id":"NCT02626338","publication_url":"https://clinicaltrials.gov/study/NCT02626338","title":"Pilot Study of Crenolanib Combined With Standard Salvage Chmetherapy in Subjects With Relapsed/Refractory Acute Myeloid Leukemia","has_exemption":true,"start_date":"2016-02-29","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Arog Pharmaceuticals, Inc.","sponsor_slug":"arog-pharmaceuticals-inc","status":"reported-late","is_pact":true,"days_late":59},{"registry_id":"NCT03391284","publication_url":"https://clinicaltrials.gov/study/NCT03391284","title":"Preemptive Oral vs Intravenous Acetominophen for Postoperative Pain in Minimally Invasive Gynecologic Surgery: A Randomized Control Trial","has_exemption":false,"start_date":"2016-02-29","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Scripps Health","sponsor_slug":"scripps-health","status":"overdue","is_pact":true,"days_late":2618},{"registry_id":"NCT02673372","publication_url":"https://clinicaltrials.gov/study/NCT02673372","title":"Low-Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department Geriatric Population: A Prospective, Randomized, Double-Blind Study.","has_exemption":false,"start_date":"2016-04-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Antonios Likourezos","sponsor_slug":"antonios-likourezos","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02809118","publication_url":"https://clinicaltrials.gov/study/NCT02809118","title":"Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment","has_exemption":false,"start_date":"2016-06-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Auris Medical, Inc.","sponsor_slug":"auris-medical-inc","status":"reported-late","is_pact":true,"days_late":421},{"registry_id":"NCT02849080","publication_url":"https://clinicaltrials.gov/study/NCT02849080","title":"Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus","has_exemption":true,"start_date":"2016-09-20","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02899689","publication_url":"https://clinicaltrials.gov/study/NCT02899689","title":"Induction of Labor in Women With Unfavorable Cervix: Randomized Control Study Comparing Dilapan to Foley Bulb","has_exemption":false,"start_date":"2016-09-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02916433","publication_url":"https://clinicaltrials.gov/study/NCT02916433","title":"Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients: A Randomized Controlled Trial","has_exemption":false,"start_date":"2016-09-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Danbury Hospital","sponsor_slug":"danbury-hospital","status":"reported-late","is_pact":true,"days_late":546},{"registry_id":"NCT02939651","publication_url":"https://clinicaltrials.gov/study/NCT02939651","title":"A Phase 2, Open-label Study of Pembrolizumab Monotherapy in Patients With Metastatic High Grade Neuroendocrine Tumors","has_exemption":false,"start_date":"2016-10-26","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"reported-late","is_pact":true,"days_late":586},{"registry_id":"NCT02946021","publication_url":"https://clinicaltrials.gov/study/NCT02946021","title":"Assessment of Lymphatic Structure and Function Pre- and Post- Treatment and During Recovery in Head and Neck Cancer Patients Using NIR Fluorescence Lymphatic Imaging","has_exemption":false,"start_date":"2016-10-31","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Tactile Medical","sponsor_slug":"tactile-medical","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02928445","publication_url":"https://clinicaltrials.gov/study/NCT02928445","title":"A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)","has_exemption":false,"start_date":"2016-10-31","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Axovant Sciences Ltd.","sponsor_slug":"axovant-sciences-ltd","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02943460","publication_url":"https://clinicaltrials.gov/study/NCT02943460","title":"A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Primary Sclerosing Cholangitis Without Cirrhosis","has_exemption":false,"start_date":"2016-11-29","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02876055","publication_url":"https://clinicaltrials.gov/study/NCT02876055","title":"Prospective, Randomized Controlled Trial Comparing Analgesic Efficacy of Single Injection vs. Continuous Interscalene Blockade vs. Local Infiltration Analgesia for Patients Undergoing Primary Total Shoulder Arthroplasty","has_exemption":false,"start_date":"2016-11-30","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported-late","is_pact":true,"days_late":1},{"registry_id":"NCT02958449","publication_url":"https://clinicaltrials.gov/study/NCT02958449","title":"Prospective Clinical Investigation for a Randomized, Controlled, Multicenter Non-inferiority Study Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu® and No Drains (Test) in Mastectomy","has_exemption":false,"start_date":"2016-12-31","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Cohera Medical, Inc.","sponsor_slug":"cohera-medical-inc","status":"overdue","is_pact":true,"days_late":2618},{"registry_id":"NCT03261336","publication_url":"https://clinicaltrials.gov/study/NCT03261336","title":"A Phase II Study of Oral Calcitriol in Combination With Ketoconazole in Castration Resistant Prostate Cancer, Progressing Despite Primary ADT and Abiraterone","has_exemption":false,"start_date":"2017-01-06","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Donald Trump, MD","sponsor_slug":"donald-trump-md","status":"reported-late","is_pact":true,"days_late":691},{"registry_id":"NCT03082573","publication_url":"https://clinicaltrials.gov/study/NCT03082573","title":"Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Were Treated With H.P. Acthar Gel After an Incomplete Response to Combinations of DMARDs and Biologic DMRADs","has_exemption":false,"start_date":"2017-03-03","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Iraj Sabahi Research Inc.","sponsor_slug":"iraj-sabahi-research-inc","status":"overdue","is_pact":false,"days_late":2618},{"registry_id":"NCT03051490","publication_url":"https://clinicaltrials.gov/study/NCT03051490","title":"A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency","has_exemption":false,"start_date":"2017-04-28","completion_date":"2018-02-28","has_results":false,"results_due":true,"sponsor_name":"Anthera Pharmaceuticals","sponsor_slug":"anthera-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03148691","publication_url":"https://clinicaltrials.gov/study/NCT03148691","title":"A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of A-101(Hydrogen Peroxide) Topical Solution in Subjects With Seborrheic Keratosis Lesions on the Trunk, Extremities, and Face","has_exemption":false,"start_date":"2017-05-17","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Aclaris Therapeutics, Inc.","sponsor_slug":"aclaris-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03304262","publication_url":"https://clinicaltrials.gov/study/NCT03304262","title":"Metaplasticity in the Human Motor Cortex: Validation of an Experimental Design and Comparison of Motor Outcome Measure Sensitivity to Change","has_exemption":false,"start_date":"2017-07-18","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"reported-late","is_pact":false,"days_late":1176},{"registry_id":"NCT03224351","publication_url":"https://clinicaltrials.gov/study/NCT03224351","title":"A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of VX-659 Combination Therapy in Subjects Aged 18 Years and Older With Cystic Fibrosis","has_exemption":true,"start_date":"2017-08-08","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03315780","publication_url":"https://clinicaltrials.gov/study/NCT03315780","title":"A Phase 4 Study to Evaluate Glucodynamic Effects of Dulaglutide in Japanese Patients With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2017-10-28","completion_date":"2018-02-28","has_results":true,"results_due":true,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00467987","publication_url":"https://clinicaltrials.gov/study/NCT00467987","title":"Effect of Androgel on Atherogenesis, Inflammation, Cardiovascular Risk Factors And Adiposity in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism.: a Prospective, Randomized and Controlled-Study","has_exemption":false,"start_date":"2007-06-01","completion_date":"2018-03-01","has_results":true,"results_due":true,"sponsor_name":"University at Buffalo","sponsor_slug":"university-at-buffalo","status":"reported-late","is_pact":true,"days_late":1769},{"registry_id":"NCT01661101","publication_url":"https://clinicaltrials.gov/study/NCT01661101","title":"A Large, International, Randomized, Placebo-controlled Trial to Assess the Impact of Dabigatran (a Direct Thrombin Inhibitor) and Omeprazole (a Proton-pump Inhibitor) in Patients Suffering Myocardial Injury After Noncardiac Surgery","has_exemption":false,"start_date":"2013-01-31","completion_date":"2018-03-01","has_results":false,"results_due":true,"sponsor_name":"Population Health Research Institute","sponsor_slug":"population-health-research-institute","status":"overdue","is_pact":true,"days_late":2617},{"registry_id":"NCT02165384","publication_url":"https://clinicaltrials.gov/study/NCT02165384","title":"Continued Evaluation of the Preceptis Medical, Inc. Tympanostomy Ear Tube Introducer","has_exemption":false,"start_date":"2014-01-31","completion_date":"2018-03-01","has_results":true,"results_due":true,"sponsor_name":"Preceptis Medical, Inc.","sponsor_slug":"preceptis-medical-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02572167","publication_url":"https://clinicaltrials.gov/study/NCT02572167","title":"A Phase 1/2 Study Evaluating Brentuximab Vedotin in Combination With Nivolumab in Patients With Relapsed or Refractory Hodgkin Lymphoma After Failure of Frontline Therapy","has_exemption":false,"start_date":"2015-10-31","completion_date":"2018-03-01","has_results":true,"results_due":true,"sponsor_name":"Seagen Inc.","sponsor_slug":"seagen-inc","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02584452","publication_url":"https://clinicaltrials.gov/study/NCT02584452","title":"Randomized Controlled Trial Evaluating Postoperative Analgesia and Muscle Strength Between Single Versus Continuous Adductor Canal Block for Ambulatory ACL Reconstruction.","has_exemption":false,"start_date":"2015-11-03","completion_date":"2018-03-01","has_results":true,"results_due":true,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported-late","is_pact":true,"days_late":213},{"registry_id":"NCT02238977","publication_url":"https://clinicaltrials.gov/study/NCT02238977","title":"Bupropion for Depression in ESRD Patients on Hemodialysis","has_exemption":false,"start_date":"2016-03-31","completion_date":"2018-03-01","has_results":true,"results_due":true,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02523222","publication_url":"https://clinicaltrials.gov/study/NCT02523222","title":"Prophylactic Dextrose Gel Does Not Prevent Neonatal Hypoglycemia: a Quasi-experimental Pilot Study","has_exemption":false,"start_date":"2016-07-01","completion_date":"2018-03-01","has_results":false,"results_due":true,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"overdue","is_pact":true,"days_late":2617},{"registry_id":"NCT03714659","publication_url":"https://clinicaltrials.gov/study/NCT03714659","title":"Clinical Evaluation of Autologous Micro-fragmented Adipose Tissue as a Treatment Option for Meniscus Tears","has_exemption":false,"start_date":"2017-01-01","completion_date":"2018-03-01","has_results":true,"results_due":true,"sponsor_name":"New Jersey Regenerative Institute, LLC","sponsor_slug":"new-jersey-regenerative-institute-llc","status":"reported-late","is_pact":true,"days_late":171},{"registry_id":"NCT03470532","publication_url":"https://clinicaltrials.gov/study/NCT03470532","title":"Comparing the Effect of 4% Articaine and 2% Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction- A Randomized Clinical Trial","has_exemption":false,"start_date":"2017-02-25","completion_date":"2018-03-01","has_results":false,"results_due":true,"sponsor_name":"Melaka Manipal Medical College","sponsor_slug":"melaka-manipal-medical-college","status":"overdue","is_pact":false,"days_late":2617},{"registry_id":"NCT03278028","publication_url":"https://clinicaltrials.gov/study/NCT03278028","title":"A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts","has_exemption":false,"start_date":"2017-07-13","completion_date":"2018-03-01","has_results":true,"results_due":true,"sponsor_name":"Aclaris Therapeutics, Inc.","sponsor_slug":"aclaris-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":6},{"registry_id":"NCT03138382","publication_url":"https://clinicaltrials.gov/study/NCT03138382","title":"Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry","has_exemption":false,"start_date":"2017-08-25","completion_date":"2018-03-01","has_results":true,"results_due":true,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported-late","is_pact":false,"days_late":81}]}